Adial Pharmaceuticals Inc (ADIL)
1.85
+0.10
(+5.71%)
USD |
NASDAQ |
May 02, 09:41
Adial Pharmaceuticals Cash and Short Term Investments (Quarterly): 2.827M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.827M |
| September 30, 2023 | 0.3159M |
| June 30, 2023 | 1.218M |
| March 31, 2023 | 2.313M |
| December 31, 2022 | 4.002M |
| September 30, 2022 | 5.753M |
| June 30, 2022 | 9.157M |
| March 31, 2022 | 12.69M |
| December 31, 2021 | 6.062M |
| September 30, 2021 | 7.180M |
| June 30, 2021 | 5.210M |
| March 31, 2021 | 5.638M |
| December 31, 2020 | 4.401M |
| September 30, 2020 | 7.365M |
| Date | Value |
|---|---|
| June 30, 2020 | 8.624M |
| March 31, 2020 | 4.952M |
| December 31, 2019 | 6.777M |
| September 30, 2019 | 8.530M |
| June 30, 2019 | 10.25M |
| March 31, 2019 | 11.39M |
| December 31, 2018 | 3.869M |
| September 30, 2018 | 4.817M |
| June 30, 2018 | 0.15M |
| March 31, 2018 | 0.054M |
| December 31, 2017 | 0.0182M |
| September 30, 2017 | 0.0403M |
| June 30, 2017 | 0.1371M |
| December 31, 2016 | 0.088M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.3159M
Minimum
Sep 2023
12.69M
Maximum
Mar 2022
5.961M
Average
5.753M
Median
Sep 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| BioVie Inc | 20.23M |
| BioSig Technologies Inc | 0.293M |
| Precision BioSciences Inc | 116.68M |
| Humacyte Inc | 80.45M |
| Monogram Orthopaedics Inc | 13.59M |